Mapping hematologists’ HIV testing behavior among lymphoma patients–A mixed-methods study
Rattachement africain : nl. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: HIV testing among patients with malignant lymphoma (PWML) is variably implemented. We evaluated HIV testing among PWML, and mapped factors influencing hematologists' testing behavior. MATERIALS: We conducted a mixed-methods study assessing HIV testing among PWML, factors influencing HIV testing and opportunities for improvement in five hospitals in the region of Amsterdam, the Netherlands. The proportion of PWML tested for HIV within 3 months before or after lymphoma diagnosis and percentage positive were assessed from January 2015 through June 2020. Questionnaires on intention, behavior and psychosocial determinants for HIV testing were conducted among hematologists. Through twelve semi-structured interviews among hematologists and authors of hematology guidelines, we further explored influencing factors and opportunities for improvement. FINDINGS: Overall, 1,612 PWML were included for analysis, including 976 patients newly diagnosed and 636 patients who were referred or with progressive/relapsed lymphoma. Seventy percent (678/976) of patients newly diagnosed and 54% (343/636) of patients with known lymphoma were tested for HIV. Overall, 7/1,021 (0.7%) PWML tested HIV positive, exceeding the 0.1% cost-effectiveness threshold. Questionnaires were completed by 40/77 invited hematologists, and 85% reported intention to test PWML for HIV. In the interviews, hematologists reported varying HIV testing strategies, including testing all PWML or only when lymphoma treatment is required. Recommendations for improved HIV testing included guideline adaptations, providing electronic reminders and monitoring and increasing awareness. CONCLUSIONS: Missed opportunities for HIV testing among PWML occurred and HIV test strategies varied among hematologists. Efforts to improve HIV testing among PWML should include a combination of approaches.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Mapping hematologists’ HIV testing behavior among lymphoma patients–A mixed-methods study
- Date Crossref
- 03/01/2023
- Éditeur
- Public Library of Science (PLoS)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Amsterdam University Medical Centers pays non établi dans la noticeÉtablissement de santé
-
University of Amsterdam Amsterdam UMC pays non établi dans la noticeUniversité ou école supérieure
-
Maastricht University Department of Work and Social Psychology pays non établi dans la noticeUniversité ou école supérieure
-
GGD Amsterdam pays non établi dans la noticeÉtablissement de santé
-
Stichting HIV Monitoring pays non établi dans la noticeInstitution
-
Amsterdam Institute for Global Health and Development pays non établi dans la noticeStructure de recherche
-
Amsterdam Institute for Infection and Immunity pays non établi dans la noticeStructure de recherche
-
Amsterdam Public Health Research Institute pays non établi dans la noticeStructure de recherche
-
Department of Infectious Diseases pays non établi dans la noticeInstitution
Amsterdam University Medical Centers, Amsterdam UMC — University of Amsterdam et Department of Work and Social Psychology — Maastricht University, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.